Two previously uncharacterized members of the Rb-Mn-P-O system, RbMnP(2)O(7) and beta-RbMnHP(3)O(10), have been synthesized using a phosphoric acid flux synthetic route and their crystal and magnetic structures determined using neutron powder diffraction. The crystal structure of RbMnP(2)O(7) (space group P2(1)/c, a = 7.3673(2) A, b = 9.6783(2) A, c = 8.6467(2) A, and beta = 105.487(1) degrees) was found to be isostructural with RbFeP(2)O(7). The polymorph beta-RbMnHP(3)O(10) was also isolated as a single phase and found to crystallize in the space group C2 (a = 12.2066(5) A, b = 8.5243(3) A, c = 8.8530(4) A, beta = 107.233(2) degrees). Both structures consist of frameworks of corner-sharing MnO(6) octahedra linked together by condensed phosphate anions, with Rb(+) cations located in the intersecting channels. In both cases the Mn(3+) octahedra exhibit unusual Jahn-Teller distortions indicative of a plasticity effect driven by the steric requirements of the condensed phosphate anions, and this causes a strong violet coloration similar to that observed in the manganese violet pigment; the structure of this has yet to be determined. Magnetic susceptibility measurements show that both RbMnP(2)O(7) (T(N) = 20 K) and beta-RbMnHP(3)O(10) (T(N) = 10 K) undergo a phase transition at low temperatures to an antiferromagnetically ordered state. Low-temperature neutron powder diffraction studies show that the magnetic ground states of each of these materials involve both ferromagnetic and antiferromagnetic super-superexchange interactions between orbitally ordered Mn(3+), which are mediated by PO(4) tetrahedra. These interactions are compared and discussed.
No takes yet. Share an insight, caveat, or question.
Coomer et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: